Analysts Forecast Modest Q1 Earnings for Health In Tech

Zacks Research projects a loss per share for the tech company's first quarter results.

Apr. 2, 2026 at 11:36am

Got story updates? Submit your updates here. ›

Equities research analysts at Zacks Research have issued their Q1 2026 earnings per share estimates for shares of Health In Tech, Inc. (NASDAQ:HIT). Zacks Research analyst M. Marin forecasts that the company will report a loss of $0.04 per share for the quarter. The analysts have also provided estimates for Health In Tech's future quarterly and annual earnings.

Why it matters

Health In Tech is a technology company that provides insurance platforms and services to the healthcare industry. Analysts' earnings projections offer insights into the company's financial performance and market expectations, which can impact investor sentiment and the stock price.

The details

According to the Zacks Research note, analyst M. Marin expects Health In Tech to report a loss of $0.04 per share for the first quarter of 2026. The analysts have also provided estimates for the company's Q2 2026 earnings at a loss of $0.03 per share, Q3 2026 earnings at a profit of $0.03 per share, Q4 2026 earnings at a profit of $0.04 per share, and full-year 2027 earnings at $0.17 per share.

  • Zacks Research issued its Q1 2026 EPS estimates on Wednesday, April 1st.

The players

Zacks Research

An equities research firm that provides analysis and estimates on publicly traded companies.

M. Marin

A Zacks Research analyst who covers Health In Tech.

Health In Tech, Inc.

A technology company that provides insurance platforms and services to the healthcare industry.

Got photos? Submit your photos here. ›

What they’re saying

“Zacks Research analyst M. Marin forecasts that the company will earn ($0.04) per share for the quarter.”

— M. Marin, Zacks Research Analyst

The takeaway

Health In Tech's upcoming Q1 2026 earnings report will be closely watched by investors and analysts to gauge the company's financial performance and market positioning in the healthcare technology space. The modest loss projected by Zacks Research suggests the company may be facing some near-term headwinds, but the analysts' longer-term forecasts indicate optimism about its future earnings potential.